ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Lineage Cell Therapeutics Inc

Lineage Cell Therapeutics Inc (LCTX)

1.04
-0.04
(-3.70%)
Closed May 20 4:00PM
1.07
0.03
( 2.88% )
Pre Market: 4:24AM

Lineage Cell Therapeutics Inc Financial Summary

The current LCTX market cap is 201.73M. The company's latest EPS is USD -0.1140 and P/E is -9.12.

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 1.92M2.39M3.23M1.25M2.09M
Operating Income -6.64M-6.64M-5.02M-6.71M-6.36M
Net Income -6.35M-4.37M-5.23M-7.11M-4.78M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 3.52M1.83M4.34M14.7M8.95M
Operating Income -38.88M-26.45M-49.21M-22.52M-24.73M
Net Income -11.71M-20.65M-43.02M-26.27M-21.49M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 123.66M113.21M111.69M106.15M101.02M
Total Liabilities 51.73M44.19M40.43M39.49M39M
Total Equity 71.94M69.02M71.26M66.66M62.02M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 125.48M107.95M174.55M123.66M101.02M
Total Liabilities 14.23M12.82M83.65M51.73M39M
Total Equity 111.25M95.13M90.9M71.94M62.02M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 1.06M-11.24M-17.51M-22.55M-28.57M
Investing -46.16M15.43M34.59M36.71M46.45M
Financing 1.63M1,0005.63M6.44M6.42M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -31.95M-19.75M-23.56M1.06M-28.57M
Investing 16.96M13.04M9.75M-46.16M46.45M
Financing 617k29.87M36.93M1.63M6.42M
Market Cap 201.73M
Price to Earnings Ratio -9.12
Price to Sales Ratio 21.94
Price to Cash Ratio 5.53
Price to Book Ratio 3.16
Dividend Yield -

Share Statistics

Shares Outstanding 188.53M
Average Volume (1 week) 1.22M
Average Volume (1 Month) 1.01M
52 Week Change -20.74%
52 Week High 1.61
52 Week Low 0.8414
Spread (Intraday) 0.06 (5.56%)

Company Info

Company Name Lineage Cell Therapeutics Inc
Address 2173 salk avenue
alameda, california 92008
Website https://lineagecell.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock